Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisabetta Poluzzi

Showing results (21-30 of 189) with videos related to

Pageof 19
Sort By:
Journal of Medicinal Chemistry|August 23, 2002
Toward a pharmacophore for drugs inducing the long QT syndrome: insights from a CoMFA study of HERG K(+) channel blockersAndrea Cavalli, Elisabetta Poluzzi, Fabrizio De Ponti, et al.
Clinical Pharmacology and Therapeutics|June 5, 2026
Major Adverse Cardiac Events with Ondansetron: The Role of Observational Evidence to Inform Actionable Safer Prescribing in Cardio-OncologyEmanuel Raschi, Igor Diemberger, Elisabetta Poluzzi, et al.
Drug Safety|August 5, 2020
Liver Injury with Ulipristal Acetate: Exploring the Underlying Pharmacological BasisMilo Gatti, Elisabetta Poluzzi, Fabrizio De Ponti, et al.
Expert Opinion on Drug Safety|August 26, 2020
Baricitinib, JAK inhibitors and liver injury: a cause for concern in COVID-19?Emanuel Raschi, Paolo Caraceni, Elisabetta Poluzzi, et al.
Journal of the American College of Cardiology|May 7, 2016
Safety Meta-Analysis: A Call for Appropriate Use of Disproportionality Measures From Spontaneous Reporting SystemsEmanuel Raschi, Francesco Salvo, Elisabetta Poluzzi, et al.
European Journal of Cancer (Oxford, England : 1990)|December 5, 2025
Letter Re: Tarlatamab-induced immune-related adverse events: Real-world pharmacovigilance study using the FAERS databaseEmanuel Raschi, Charles Khouri, Elisabetta Poluzzi, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 19, 2017
Adverse pregnancy outcomes in women exposed to gabapentin and pregabalin: data from a population-based studyBarbara Mostacci, Elisabetta Poluzzi, Roberto D'Alessandro, et al.
Annals of the Rheumatic Diseases|June 14, 2019
Drug-induced systemic lupus erythematosus: should immune checkpoint inhibitors be added to the evolving list?Emanuel Raschi, Ippazio Cosimo Antonazzo, Elisabetta Poluzzi, et al.
Regulatory Toxicology and Pharmacology : RTP|March 1, 2011
Excipients in medicinal products used in gastroenterology as a possible cause of side effectsMaria Grazia Ursino, Elisabetta Poluzzi, Carla Caramella, et al.
Pharmacological Research|July 1, 2004
Antibacterial macrolides: a drug class with a complex pharmacological profileEman Abu-Gharbieh, Valentina Vasina, Elisabetta Poluzzi, et al.
Pageof 19

Showing results (21-30 of 189) with videos related to

Sort By:
Pageof 19
Journal of Medicinal Chemistry|August 23, 2002
Toward a pharmacophore for drugs inducing the long QT syndrome: insights from a CoMFA study of HERG K(+) channel blockersAndrea Cavalli, Elisabetta Poluzzi, Fabrizio De Ponti, et al.
Clinical Pharmacology and Therapeutics|June 5, 2026
Major Adverse Cardiac Events with Ondansetron: The Role of Observational Evidence to Inform Actionable Safer Prescribing in Cardio-OncologyEmanuel Raschi, Igor Diemberger, Elisabetta Poluzzi, et al.
Drug Safety|August 5, 2020
Liver Injury with Ulipristal Acetate: Exploring the Underlying Pharmacological BasisMilo Gatti, Elisabetta Poluzzi, Fabrizio De Ponti, et al.
Expert Opinion on Drug Safety|August 26, 2020
Baricitinib, JAK inhibitors and liver injury: a cause for concern in COVID-19?Emanuel Raschi, Paolo Caraceni, Elisabetta Poluzzi, et al.
Journal of the American College of Cardiology|May 7, 2016
Safety Meta-Analysis: A Call for Appropriate Use of Disproportionality Measures From Spontaneous Reporting SystemsEmanuel Raschi, Francesco Salvo, Elisabetta Poluzzi, et al.
European Journal of Cancer (Oxford, England : 1990)|December 5, 2025
Letter Re: Tarlatamab-induced immune-related adverse events: Real-world pharmacovigilance study using the FAERS databaseEmanuel Raschi, Charles Khouri, Elisabetta Poluzzi, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 19, 2017
Adverse pregnancy outcomes in women exposed to gabapentin and pregabalin: data from a population-based studyBarbara Mostacci, Elisabetta Poluzzi, Roberto D'Alessandro, et al.
Annals of the Rheumatic Diseases|June 14, 2019
Drug-induced systemic lupus erythematosus: should immune checkpoint inhibitors be added to the evolving list?Emanuel Raschi, Ippazio Cosimo Antonazzo, Elisabetta Poluzzi, et al.
Regulatory Toxicology and Pharmacology : RTP|March 1, 2011
Excipients in medicinal products used in gastroenterology as a possible cause of side effectsMaria Grazia Ursino, Elisabetta Poluzzi, Carla Caramella, et al.
Pharmacological Research|July 1, 2004
Antibacterial macrolides: a drug class with a complex pharmacological profileEman Abu-Gharbieh, Valentina Vasina, Elisabetta Poluzzi, et al.
Pageof 19